EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseNetzwerk-Metaanalyse

Direct Oral Anticoagulants for Prevention of Venous Thromboembolism after Cancer-Related Surgery: Systematic Review and Network Meta-Analysis

Gerardo N Pititto, Giorgio Maraziti, Alessandro Squizzato iD, Cecilia Becattini

Thrombosis and Haemostasis · 01.04.2026 · 126 (04) · 429-438

DOI: 10.1055/a-2628-3967 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.04.2026. Verfasst von Gerardo N Pititto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Residency Program, School of Medicine, University of Insubria, Varese and Como, Italy. Hauptthemen laut MEDLINE: Venous Thromboembolism, Neoplasms, Anticoagulants, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The risk of venous thromboembolism (VTE) is high after cancer surgery and is reduced by antithrombotic prophylaxis. We conducted a systematic review and network meta-analysis to evaluate the effectiveness and safety of direct oral anticoagulants (DOACs) for VTE prophylaxis after cancer surgery. The primary study outcome was 30-day VTE after surgery. Pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated. Five randomized controlled trials (RCTs; two gynecological, one abdominal, one neurosurgical, and one thoracic; 1,694 patients) and seven observational studies (three urological, two abdominal, and two gynecological; 2,042 patients) were included. DOACs reduced the incidence of 30-day (OR 0.52, 95% CI 0.27-0.98, I2 22.7%) and 90-day VTE (OR 0.51, 95% CI 0.28-0.92, I2 0%) compared to LMWH. No difference was observed between DOACs and LMWH in 30 and 90-day bleeding outcomes. In random effect analyses, apixaban (OR 0.31, 95% CI 0.11-0.84) and not rivaroxaban reduced the risk of 30 day-VTE compared to LMWH (OR 0.69, 95% CI 0.35-1.34) without increasing the risk of bleeding at 30 or 90 days. No difference in the risk of VTE or bleeding was observed between DOACs and placebo/no treatment, but these analyses were probably underpowered. Subgroup analyses were conducted on LMWH pre-treatment, extended prophylaxis, duration of surgery, and type of surgery. Our study supports apixaban and rivaroxaban as promising alternatives to LMWH in post-operative prophylaxis of VTE after cancer surgery. Further high-quality data are needed in specific surgical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismNeoplasmsAnticoagulantsPostoperative ComplicationsFactor Xa InhibitorsHumansAdministration, OralNetwork Meta-Analysis as TopicPyridonesTreatment OutcomeRisk FactorsRandomized Controlled Trials as TopicHemorrhageRivaroxabanFemalePyrazolesHeparin, Low-Molecular-Weight

Substanzen

AnticoagulantsPyridonesapixabanRivaroxabanFactor Xa InhibitorsPyrazolesHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Internal Medicine Residency Program, School of Medicine, University of Insubria, Varese and Como, Italy.
  • Internal, Vascular and Emergency Medicine - Stroke Unit, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Department of Medicine and Surgery, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria - ASST Lariana, Como, Italy.

ORCID-Profile: Alessandro Squizzato

Zitieren

APA

Pititto, G. N., Maraziti, G., Squizzato, A., & Becattini, C. (2026). Direct Oral Anticoagulants for Prevention of Venous Thromboembolism after Cancer-Related Surgery: Systematic Review and Network Meta-Analysis. Thrombosis and Haemostasis, 126(04), 429-438. https://doi.org/10.1055/a-2628-3967

Vancouver

Pititto GN, Maraziti G, Squizzato A, Becattini C. Direct Oral Anticoagulants for Prevention of Venous Thromboembolism after Cancer-Related Surgery: Systematic Review and Network Meta-Analysis. Thrombosis and Haemostasis. 2026;126(04):429-438. doi:10.1055/a-2628-3967

BibTeX
@article{Pititto2026,
  author = {Pititto, Gerardo N and Maraziti, Giorgio and Squizzato, Alessandro and Becattini, Cecilia},
  title = {Direct Oral Anticoagulants for Prevention of Venous Thromboembolism after Cancer-Related Surgery: Systematic Review and Network Meta-Analysis},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {04},
  pages = {429--438},
  doi = {10.1055/a-2628-3967}
}
Kostenlos starten →